Follicular Thyroid Carcinoma
📧 Sign up to get email alerts when something new happens for Follicular Thyroid Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Health and Wellness Coaching to Improve Adherence to Healthy Habits and Treatment Plans in Papillary and Follicular Thyroid Cancer Survivors [NA]
A Mayo Clinic-led clinical trial update describes a study evaluating health and wellness coaching to improve adherence to healthy habits and…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Personalized Cancer Support (Thrive Track) to Manage the Emotional Needs of Young Adults With Thyroid, Melanoma and Testicular Cancer, PerCS-YA Trial [NA]
A ClinicalTrials.gov update for the Thrive Track trial aimed at managing emotional support for young adults with thyroid cancer, melanoma, a…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Urinary Exosomal Biomarkers of Thyroglobulin and Galectin-3 for Prognosis and Follow-up in Patients of Thyroid Cancer
A clinical trial update for a study assessing urinary exosomal biomarkers (thyroglobulin and galectin-3) to predict prognosis and monitor th…
-
CLINICAL_TRIALS trial_result · 2026-03-11Clinical Trial Update: Durvalumab Plus Tremelimumab for the Treatment of Patients With Progressive, Refractory Advanced Thyroid Carcinoma -The DUTHY Trial [Phase 2]
Phase 2 trial evaluating durvalumab plus tremelimumab in progressive, refractory advanced thyroid carcinoma (papillary and follicular subtyp…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Evaluation of 18F-TFB PET/CT Scan in Patients With Differentiated Thyroid Cancer
A Mayo Clinic-sponsored clinical study is evaluating the 18F-TFB PET/CT scan for imaging differentiated thyroid cancers; the trial is curren…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-02-02Clinical Trial Update: Vemurafenib and Cobimetinib for the Treatment of Patients With High Risk Differentiated Thyroid Carcinoma With BRAFV600E Mutation [Phase 2]
Phase 2 clinical trial evaluating the combination of vemurafenib and cobimetinib in high-risk differentiated thyroid carcinoma with BRAFV600…
-
CLINICAL_TRIALS trial_result · 2025-10-31Clinical Trial Update: Testing the Combination of Cabozantinib, Nivolumab, and Ipilimumab (CaboNivoIpi) for Advanced Differentiated Thyroid Cancer [Phase 2]
Phase 2 trial update reports results from CaboNivoIpi (cabozantinib, nivolumab, ipilimumab) in advanced differentiated thyroid cancer, inclu…
-
CLINICAL_TRIALS trial_result · 2025-08-24Clinical Trial Update: Dabrafenib With or Without Trametinib in Treating Patients With Advanced Differentiated Thyroid Cancer [Phase 2]
Phase 2 trial evaluating dabrafenib with or without trametinib in advanced differentiated thyroid carcinoma, including follicular, papillary…
-
CLINICAL_TRIALS research · 2025-06-11Clinical Trial Update: XL092 for the Treatment of Locally Advanced or Metastatic Radioiodine Refractory Differentiated Thyroid Cancer [Phase 2]
Phase 2 clinical trial update indicating that XL092 for locally advanced or metastatic radioiodine-refractory differentiated thyroid cancer …
-
CLINICAL_TRIALS trial_result · 2025-04-22Clinical Trial Update: Radioiodine Planar and a SPECT/CT Imaging With Iodine-123 for Evaluation of Follicular Thyroid Nodules Prior to Surgery
A Mayo Clinic study evaluating iodine-123 planar and SPECT/CT imaging to evaluate follicular thyroid nodules prior to surgery has completed.
-
CLINICAL_TRIALS trial_result · 2025-04-01Clinical Trial Update: Evaluation of 177Lu-DOTA-EB-FAPI in Patients With Metastatic Radioactive Iodine Refractory Thyroid Cancer [Phase 1]
Phase 1 clinical trial evaluating Lutetium-177 DOTA-EB-FAPI in patients with metastatic, radioiodine-refractory thyroid cancer has completed…
-
CLINICAL_TRIALS research · 2025-03-17Clinical Trial Update: Observational Study Analysing the Transcriptome and Mutational Status of Thyroid Carcinomas of Follicular Origin with Different Degrees of Malignancy
Observational clinical trial update analyzing the transcriptome and mutational status of thyroid carcinomas of follicular origin across diff…
-
CLINICAL_TRIALS research · 2024-12-12Clinical Trial Update: Restor. I-131 Upt. + Selpercatinib in RET F-P RAI-R TC [Phase 2]
Phase 2 trial assessing restoration of I-131 uptake with selpercatinib in RET fusion-positive, radioiodine-refractory thyroid cancer; curren…
-
CLINICAL_TRIALS trial_result · 2023-10-24Clinical Trial Update: Lenvatinib and Pembrolizumab in Differentiated Thyroid Cancers (DTC) [Phase 2]
A Phase 2 trial evaluating the combination of lenvatinib and pembrolizumab in differentiated thyroid cancers has completed, with results pos…
-
CLINICAL_TRIALS trial_result · 2022-12-28Clinical Trial Update: Trametinib in Increasing Tumoral Iodine Incorporation in Patients With Recurrent or Metastatic Thyroid Cancer [Phase 2]
Phase 2 trial evaluating trametinib for increasing tumoral iodine incorporation in patients with recurrent or metastatic thyroid cancer; res…
-
CLINICAL_TRIALS trial_result · 2021-08-03Clinical Trial Update: Iodine I-131 With or Without Selumetinib in Treating Patients With Recurrent or Metastatic Thyroid Cancer [Phase 2]
Phase 2 trial evaluating whether adding selumetinib to radioactive iodine improves outcomes in patients with recurrent or metastatic thyroid…
-
CLINICAL_TRIALS trial_result · 2021-07-15Clinical Trial Update: Cediranib Maleate With or Without Lenalidomide for the Treatment of Thyroid Cancer [Phase 1, Phase 2]
Clinical trial update for cediranib maleate with or without lenalidomide in thyroid cancer completed; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2018-04-03Clinical Trial Update: Cabozantinib-S-Malate in Treating Patients With Refractory Thyroid Cancer [Phase 2]
Phase 2 trial of cabozantinib-s-malate in patients with refractory thyroid cancer has been completed, with results posted in 2018. The study…
-
CLINICAL_TRIALS trial_result · 2017-09-15Clinical Trial Update: Sunitinib Malate in Treating Patients With Thyroid Cancer That Did Not Respond to Iodine I 131 and Cannot Be Removed by Surgery [Phase 2]
This Phase 2 trial evaluated Sunitinib malate in iodine-refractory thyroid cancers, including differentiated and medullary subtypes. Results…
-
CLINICAL_TRIALS trial_result · 2017-03-15Clinical Trial Update: Aflibercept in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer That Did Not Respond to Radioactive Iodine Therapy [Phase 2]
Phase 2 trial evaluating aflibercept in patients with recurrent or metastatic thyroid cancer that did not respond to radioactive iodine; the…
-
CLINICAL_TRIALS trial_result · 2016-12-14Clinical Trial Update: A Phase II Trial of Valproic Acid in Patients With Advanced Thyroid Cancers of Follicular Cell Origin [Phase 2]
Phase II trial evaluating valproic acid in patients with advanced thyroid cancers of follicular cell origin completed; results have been pos…
-
CLINICAL_TRIALS trial_result · 2014-08-11Clinical Trial Update: Suberoylanilide Hydroxamic Acid in Treating Patients With Metastatic and/or Locally Advanced or Locally Recurrent Thyroid Cancer [Phase 2]
Phase 2 trial evaluating the histone deacetylase inhibitor suberoylanilide hydroxamic acid (vorinostat) in patients with metastatic and/or l…
-
CLINICAL_TRIALS trial_result · 2013-09-19Clinical Trial Update: A Drug-Drug Interaction Study of the Effects of XL184 (Cabozantinib) on Rosiglitazone in Subjects With Solid Tumors [Phase 1]
Phase 1 study evaluating the drug-drug interaction between cabozantinib (XL184) and rosiglitazone in subjects with solid tumors; the trial h…